Endoscopic submucosal dissection for early esophageal squamous cell carcinoma: long-term results from a Western cohort
Endoscopy · 01.05.2024 · 56 (05) · 325-333
DOI: 10.1055/a-2245-7235 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Endoscopy, erschienen am 01.05.2024. Verfasst von Ilse N Beaufort und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology and Hepatology, University Medical Center Utrecht, Utrecht University, Utrecht, Netherlands. Hauptthemen laut MEDLINE: Endoscopic Mucosal Resection, Esophageal Neoplasms, Esophageal Squamous Cell Carcinoma. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 18 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Although endoscopic submucosal dissection (ESD) is established as first-choice treatment for early esophageal squamous cell carcinoma (ESCC) worldwide, most data are derived from Asian studies. We aimed to evaluate the long-term outcomes of ESD for patients with early ESCC in a Western cohort.
Methods
In this retrospective cohort study, patients with early ESCC amenable to ESD were included from four tertiary referral hospitals in the Netherlands between 2012 and 2017. All ESD procedures were performed by experienced endoscopists, after which the decision for additional treatment was made on a per-patient basis. Outcomes were curative resection rate, ESCC-specific survival, and overall survival.
Results
Of 68 included patients (mean age 69 years; 34 males), ESD was technically successful in 66 (97%; 95%CI 93%–100%), with curative resection achieved in 34/66 (52%; 95%CI 39%–64%). Among patients with noncurative resection, 15/32 (47%) underwent additional treatment, mainly esophagectomy (n = 10) or definitive chemoradiation therapy (n = 4). Endoscopic surveillance was preferred in 17/32 patients (53%), based on severe comorbidities or patient choice. Overall, 31/66 patients (47%) died during a median follow-up of 66 months; 8/31 (26%) were ESCC-related deaths. The 5-year overall and ESCC-specific survival probabilities were 62% (95%CI 52%–75%) and 86% (95%CI 77%–96%), respectively.
Conclusion
In this Western cohort with long-term follow-up, the effectiveness and safety of ESD for early ESCC was confirmed, although the rate of noncurative resections was substantial. Irrespective of curative status, the long-term prognosis of these patients was limited mainly due to competing mortality.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Department of Gastroenterology and Hepatology, University Medical Center Utrecht, Utrecht University, Utrecht, Netherlands.
- Department of Gastroenterology and Hepatology, St. Antonius Hospital, Nieuwegein, Netherlands.
- Department of Pathology, University Medical Center Utrecht, Utrecht University, Utrecht, Netherlands.
- Department of Gastroenterology and Hepatology, Erasmus MC Cancer Institute, University Medical Center, Rotterdam, Netherlands.
- Department of Gastroenterology and Hepatology, Amsterdam University Medical Centers, Amsterdam, Netherlands.
ORCID-Profile: Charlotte N Frederiks, Anouk Overwater, Arjun D Koch
Zitieren
APA
Beaufort, I. N., Frederiks, C. N., Overwater, A., Brosens, L. A. A., Koch, A. D., Pouw, R. E., Bergman, J. J. G. H. M., & Weusten, B. L. A. M. (2024). Endoscopic submucosal dissection for early esophageal squamous cell carcinoma: long-term results from a Western cohort. Endoscopy, 56(05), 325-333. https://doi.org/10.1055/a-2245-7235
Vancouver
Beaufort IN, Frederiks CN, Overwater A, Brosens LAA, Koch AD, Pouw RE, et al. Endoscopic submucosal dissection for early esophageal squamous cell carcinoma: long-term results from a Western cohort. Endoscopy. 2024;56(05):325-333. doi:10.1055/a-2245-7235
BibTeX
@article{Beaufort2024,
author = {Beaufort, Ilse N and Frederiks, Charlotte N and Overwater, Anouk and Brosens, Lodewijk A A and Koch, Arjun D and Pouw, Roos E and Bergman, Jacques J G H M and Weusten, Bas L A M},
title = {Endoscopic submucosal dissection for early esophageal squamous cell carcinoma: long-term results from a Western cohort},
journal = {Endoscopy},
year = {2024},
volume = {56},
number = {05},
pages = {325--333},
doi = {10.1055/a-2245-7235}
}
EUVIMED